Cyclin A1 (CCNA1) inhibits osteoporosis by suppressing transforming growth factor-beta (TGF-beta) pathway in osteoblasts.

CCNA1 Dexamethasone Osteogenesis Osteoporosis SMAD TGF-beta

Journal

BMC musculoskeletal disorders

ISSN: 1471-2474

Titre abrégé: BMC Musculoskelet Disord

Pays: England

ID NLM: 100968565

Informations de publication

Date de publication:
07 Mar 2024

Historique:

received: 19 07 2023

accepted: 22 02 2024

medline: 8 3 2024

pubmed: 8 3 2024

entrez: 8 3 2024

Statut: epublish

Résumé

Osteoporosis is a genetic disease caused by the imbalance between osteoblast-led bone formation and osteoclast-induced bone resorption. However, further gene-related pathogenesis remains to be elucidated. The aberrant expressed genes in osteoporosis was identified by analyzing the microarray profile GSE100609. Serum samples of patients with osteoporosis and normal group were collected, and the mRNA expression of candidate genes was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The mouse cranial osteoblast MC3T3-E1 cells were treated with dexamethasone (DEX) to mimic osteoporosis in vitro. Alizarin Red staining and alkaline phosphatase (ALP) staining methods were combined to measure matrix mineralization deposition of MC3T3-E1 cells. Meanwhile, the expression of osteogenesis related genes including alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OPN), Osterix, and bone morphogenetic protein 2 (BMP2) were evaluated by qRT-PCR and western blotting methods. Then the effects of candidate genes on regulating impede bone loss caused by ovariectomy (OVX) in mice were studied. Cyclin A1 (CCNA1) was found to be significantly upregulated in serum of osteoporosis patients and the osteoporosis model cells, which was in line with the bioinformatic analysis. The osteogenic differentiation ability of MC3T3-E1 cells was inhibited by DEX treatment, which was manifested by decreased Alizarin Red staining intensity, ALP staining intensity, and expression levels of ALP, OCN, OPN, Osterix, and BMP2. The effects of CCNA1 inhibition on regulating osteogenesis were opposite to that of DEX. Then, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis demonstrated that genes negatively associated with CCNA1 were enriched in the TGF-beta signaling pathway. Inhibitor of TGF-beta signaling pathway partly reversed osteogenesis induced by suppressed CCNA1. Furthermore, suppressed CCNA1 relieved bone mass of OVX mice in vivo. Downregulation of CCNA1 could activate TGF-beta signaling pathway and promote bone formation, thus playing a role in treatment of osteoporosis.

Sections du résumé

BACKGROUND BACKGROUND

METHODS METHODS

The aberrant expressed genes in osteoporosis was identified by analyzing the microarray profile GSE100609. Serum samples of patients with osteoporosis and normal group were collected, and the mRNA expression of candidate genes was detected by quantitative real-time polymerase chain reaction (qRT-PCR). The mouse cranial osteoblast MC3T3-E1 cells were treated with dexamethasone (DEX) to mimic osteoporosis in vitro. Alizarin Red staining and alkaline phosphatase (ALP) staining methods were combined to measure matrix mineralization deposition of MC3T3-E1 cells. Meanwhile, the expression of osteogenesis related genes including alkaline phosphatase (ALP), osteocalcin (OCN), osteopontin (OPN), Osterix, and bone morphogenetic protein 2 (BMP2) were evaluated by qRT-PCR and western blotting methods. Then the effects of candidate genes on regulating impede bone loss caused by ovariectomy (OVX) in mice were studied.

RESULTS RESULTS

Cyclin A1 (CCNA1) was found to be significantly upregulated in serum of osteoporosis patients and the osteoporosis model cells, which was in line with the bioinformatic analysis. The osteogenic differentiation ability of MC3T3-E1 cells was inhibited by DEX treatment, which was manifested by decreased Alizarin Red staining intensity, ALP staining intensity, and expression levels of ALP, OCN, OPN, Osterix, and BMP2. The effects of CCNA1 inhibition on regulating osteogenesis were opposite to that of DEX. Then, Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis demonstrated that genes negatively associated with CCNA1 were enriched in the TGF-beta signaling pathway. Inhibitor of TGF-beta signaling pathway partly reversed osteogenesis induced by suppressed CCNA1. Furthermore, suppressed CCNA1 relieved bone mass of OVX mice in vivo.

CONCLUSION CONCLUSIONS

Downregulation of CCNA1 could activate TGF-beta signaling pathway and promote bone formation, thus playing a role in treatment of osteoporosis.

Identifiants

DOI: 10.1186/s12891-024-07303-6 PMID: 38454404

pubmed: 38454404

doi: 10.1186/s12891-024-07303-6

pii: 10.1186/s12891-024-07303-6

doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

Pagination

206

Informations de copyright

Références

Lupsa BC, Insogna K. Bone Health and osteoporosis. Endocrin Metab Clin. [Journal Article; Review]. 2015 2015-09-01;44(3):517–30.

Zhang L, Yin X, Wang J, Xu D, Wang Y, Yang J et al. Associations between VDR Gene Polymorphisms and osteoporosis risk and bone Mineral Density in Postmenopausal women: a systematic review and Meta-analysis. SCI REP-UK. [Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov’t; Review; Systematic Review; Retracted Publication]. 2018 2018-01-17;8(1):981.

Black DM, Rosen CJ. Clinical Practice. Postmenopausal Osteoporosis. New Engl J Med. [Journal Article; Review]. 2016 2016-01-21;374(3):254 – 62.

Yin N, Zhu L, Ding L, Yuan J, Du L, Pan M et al. MiR-135-5p promotes osteoblast differentiation by targeting HIF1AN in MC3T3-E1 cells. Cell Mol Biol Lett. [Journal Article]. 2019 2019-01-20;24:51.

Rachner TD, Khosla S, Hofbauer LC. Osteoporosis: now and the future. Lancet. [Journal Article; Research Support, Non-U.S. Gov’t; Review]. 2011 2011-04-09;377(9773):1276–87.

Florencio-Silva R, Sasso GRDS, Sasso-Cerri E, Simões MJ, Cerri PS, Lattanzi W. Biology of Bone tissue: structure, function, and factors that influence bone cells. Biomed Res INT. 2015 2015-01-01;2015:421717–46.

Long Z, Dou P, Cai W, Mao M, Wu R. MiR-181a-5p promotes osteogenesis by targeting BMP3. Aging (Albany NY). [Journal Article; Research Support, Non-U.S. Gov’t]. 2023 2023-02-03;15(3):734–47.

Radonova L, Pauerova T, Jansova D, Danadova J, Skultety M, Kubelka M et al. Cyclin A1 in Oocytes prevents chromosome segregation and anaphase entry. SCI REP-UK. [Journal Article; Research Support, Non-U.S. Gov’t]. 2020 2020-05-04;10(1):7455.

Chen Y, Zhao ZX, Huang F, Yuan XW, Deng L, Tang D. MicroRNA-1271 functions as a potential tumor suppressor in hepatitis B virus-associated hepatocellular carcinoma through the AMPK signaling pathway by binding to CCNA1. J Cell Physiol. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-04-01;234(4):3555–69.

Yang B, Miao S, Zhang LN, Sun HB, Xu ZN, Han CS. Correlation of CCNA1 promoter methylation with malignant tumors: a meta-analysis introduction. Biomed Res INT. [Journal Article; Meta-Analysis; Retracted Publication]. 2015 2015-01-20;2015:134027.

Zhao R, Tao L, Qiu S, Shen L, Tian Y, Gong Z et al. Melatonin rescues glucocorticoid-induced inhibition of osteoblast differentiation in MC3T3-E1 cells via the PI3K/AKT and BMP/Smad signalling pathways. LIFE SCI. 2020 2020-01-01;257:118044.

Zheng Y, Xiao Y, Zhang D, Zhang S, Ouyang J, Li L et al. Geniposide ameliorated Dexamethasone-Induced cholesterol Accumulation in Osteoblasts by mediating the GLP-1R/ABCA1 Axis. Cells-Basel. [Journal Article; Research Support, Non-U.S. Gov’t]. 2021 2021-12-06;10(12).

Xie B, Zeng Z, Liao S, Zhou C, Wu L, Xu D. Kaempferol ameliorates the inhibitory activity of Dexamethasone in the Osteogenesis of MC3T3-E1 cells by JNK and p38-MAPK pathways. Front Pharmacol. [Journal Article]. 2021 2021-01-20;12:739326.

Qi M, Zhang L, Ma Y, Shuai Y, Li L, Luo K et al. Autophagy maintains the function of bone marrow mesenchymal stem cells to prevent Estrogen Deficiency-Induced osteoporosis. Theranostics [Journal Article]. 2017 2017-01-20;7(18):4498–516.

Li J, Li X, Liu D, Hamamura K, Wan Q, Na S et al. eIF2α signaling regulates autophagy of osteoblasts and the development of osteoclasts in OVX mice. Cell Death Dis. 2019 2019-01-01;10(12):915–21.

Chen S, Chen X, Geng Z, Su J. The horizon of bone organoid: a perspective on construction and application. Bioact Mater. 2022 2022-01-01;18:15–25.

Xue X, Hu Y, Wang S, Chen X, Jiang Y, Su J. Fabrication of physical and chemical crosslinked hydrogels for bone tissue engineering. Bioact Mater. 2022;12:327–39.

pubmed: 35128180

Qiu Z, Li L, Huang Y, Shi K, Zhang L, Huang C et al. Puerarin specifically disrupts osteoclast activation via blocking integrin-β3 Pyk2/Src/Cbl signaling pathway. J Orthop Transl. 2022 2022-01-01;33:55–69.

Lee WC, Guntur AR, Long F, Rosen CJ. Energy Metabolism of the osteoblast: implications for osteoporosis. ENDOCR REV. [Journal Article; Review; Research Support, N.I.H., Extramural]. 2017 2017-06-01;38(3):255–66.

Greenblatt MB, Tsai JN, Wein MN. Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. CLIN CHEM. [Journal Article; Review]. 2017 2017-02-01;63(2):464–74.

Jain S, Camacho P. Use of bone turnover markers in the management of osteoporosis. CURR OPIN ENDOCRINOL. [Journal Article; Review]. 2018 2018-12-01;25(6):366–72.

Cai N, Li C, Wang F. Silencing of LncRNA-ANCR promotes the Osteogenesis of osteoblast cells in postmenopausal osteoporosis via Targeting EZH2 and RUNX2. Yonsei Med J. [Journal Article]. 2019 2019-08-01;60(8):751–9.

Munoz J, Akhavan NS, Mullins AP, Arjmandi BH. Macrophage polarization and osteoporosis: a review. Nutrients. [Journal Article; Review]. 2020 2020-09-30;12(10).

Filip R, Radzki RP, Bienko M. Novel insights into the relationship between nonalcoholic fatty liver disease and osteoporosis. Clin Interv Aging. [Journal Article; Review]. 2018 2018-01-20;13:1879–91.

Chen X, Hua W, Huang X, Chen Y, Zhang J, Li G. Regulatory Role of RNA N(6)-Methyladenosine modification in Bone Biology and osteoporosis. Front Endocrinol. [Journal Article; Review]. 2019 2019-01-20;10:911.

Cai P, Lu Y, Yin Z, Wang X, Zhou X, Li Z. Baicalein ameliorates osteoporosis via AKT/FOXO1 signaling. Aging (Albany, NY.). 2021 2021-01-01;13(13):17370–9.

Orkin SH, Bauer DE. Emerging Genetic Therapy for Sickle Cell Disease. ANNU REV MED. [Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov’t; Review]. 2019 2019-01-27;70:257 – 71.

Brody H. Gene therapy. Nature. [Editorial; Introductory Journal Article]. 2018 2018-12-01;564(7735):S5.

Lin C, Yu S, Jin R, Xiao Y, Pan M, Pei F et al. Circulating miR-338 cluster activities on osteoblast differentiation: potential diagnostic and therapeutic targets for postmenopausal osteoporosis. Theranostics. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-01-20;9(13):3780–97.

Raehtz S, Bierhalter H, Schoenherr D, Parameswaran N, McCabe LR. Estrogen Deficiency exacerbates type 1 Diabetes-Induced Bone TNF-alpha expression and osteoporosis in female mice. Endocrinology. [Journal Article; Research Support, Non-U.S. Gov’t]. 2017 2017-07-01;158(7):2086–101.

Liu H, Zhao H, Lin H, Li Z, Xue H, Zhang Y et al. Relationship of COL9A1 and SOX9 genes with genetic susceptibility of postmenopausal osteoporosis. Calcified Tissue Int. [Journal Article]. 2020 2020-03-01;106(3):248–55.

Kim YH, Jang WG, Oh SH, Kim JW, Lee MN, Song JH et al. Fenofibrate induces PPARalpha and BMP2 expression to stimulate osteoblast differentiation. Biochem Bioph Res Co. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-12-03;520(2):459–65.

Hou Z, Wang Z, Tao Y, Bai J, Yu B, Shen J et al. KLF2 regulates osteoblast differentiation by targeting of Runx2. Lab Invest. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-02-01;99(2):271–80.

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. [Journal Article; Review]. 2016 2016-07-01;23(7):1128–39.

Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic differentiation of mesenchymal stem cells is regulated by osteocyte and osteoblast cells in a simplified bone niche. Eur Cells Mater. [Comparative study; Journal Article; Research Support, Non-U.S. Gov’t]. 2012 2012-01-12;23:13–27.

Ciubean AD, Ungur RA, Irsay L, Ciortea VM, Borda IM, Dogaru GB et al. Polymorphisms of FDPS, LRP5, SOST and VKORC1 genes and their relation with osteoporosis in postmenopausal Romanian women. Plos One. [Journal Article; Observational Study]. 2019 2019-01-20;14(11):e225776.

Weivoda MM, Youssef SJ, Oursler MJ. Sclerostin expression and functions beyond the osteocyte. BONE. [Journal Article; Review; Research Support, Non-U.S. Gov’t; Research Support, N.I.H., Extramural]. 2017 2017-03-01;96:45–50.

Bonnet N, Bourgoin L, Biver E, Douni E, Ferrari S. RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass. J Clin Invest. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-05-23;129(8):3214–23.

Lv F, Cai X, Yang W, Gao L, Chen L, Wu J et al. Denosumab or romosozumab therapy and risk of cardiovascular events in patients with primary osteoporosis: systematic review and meta- analysis. BONE. [Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov’t; Systematic Review]. 2020 2020-01-01;130:115121.

Ruaro B, Casabella A, Paolino S, Pizzorni C, Ghio M, Seriolo C et al. Dickkopf-1 (Dkk-1) serum levels in systemic sclerosis and rheumatoid arthritis patients: correlation with the trabecular bone score (TBS). Clin Rheumatol. [Journal Article]. 2018 2018-11-01;37(11):3057–62.

Qin Z, Li S, Zhang X, Liu G, Gu M, Zhang N et al. Combination therapy of Wuweizi (Schisandrae Chinensis Fructus) and dexamethasone alleviated Dexamethasone-Induced glucocorticoid osteoporosis in rats with idiopathic pulmonary fibrosis. Biomed Res Int. [Journal Article]. 2020 2020-01-20;2020:6301697.

Han D, Gu X, Gao J, Wang Z, Liu G, Barkema HW et al. Chlorogenic acid promotes the Nrf2/HO-1 anti-oxidative pathway by activating p21(Waf1/Cip1) to resist dexamethasone-induced apoptosis in osteoblastic cells. Free Radical Bio Med. [Journal Article; Research Support, Non-U.S. Gov’t]. 2019 2019-06-01;137:1–12.

Morikawa M, Derynck R, Miyazono K. TGF-beta and the TGF-beta family: context-dependent roles in cell and tissue physiology. CSH Perspect Biol. [Journal Article; Review]. 2016 2016-05-02;8(5).

Clark DA, Coker R. Transforming growth factor-beta (TGF-beta). INT J Biochem Cell B. [Journal Article; Review]. 1998 1998-03-01;30(3):293–8.